This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business partnership

OptimizeRx and DeepIntent Partner

Analysis based on 6 articles · First reported May 21, 2026 · Last updated May 21, 2026

Sentiment
60
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The partnership between OptimizeRx and DeepIntent is expected to positively impact the healthcare advertising market by providing life sciences marketers with more efficient and privacy-safe ways to reach healthcare providers. This collaboration could lead to increased revenue and market share for both OptimizeRx and DeepIntent, potentially boosting their stock performance and valuation.

Healthcare Advertising Technology

OptimizeRx, a healthcare technology company, announced a partnership with DeepIntent, a healthcare demand-side platform (DSP). DeepIntent will be the first DSP to integrate OptimizeRx's proprietary electronic health record (EHR) network into its healthcare advertising platform. This collaboration aims to provide life sciences marketers with an easier way to activate advertising within healthcare provider (HCP) workflows, using programmatic tools. The integration addresses the growing demand for privacy-safe advertising solutions tied to real clinical workflows and is expected to be available in Q3 2026. Both Steve Silvestro, CEO of OptimizeRx, and Lisa Kopp Johnson, Chief Revenue Officer of DeepIntent, highlighted the benefits of this partnership for delivering timely and relevant information to support informed care decisions and better patient outcomes.

priv
DeepIntent is integrating OptimizeRx's EHR network into its platform, which will enrich its healthcare DSP capabilities and offer its clients more comprehensive advertising solutions.
Importance 100.0 Sentiment 70.0
stock
OptimizeRx is expanding programmatic access to its authenticated EHR network through this partnership, enhancing its market position and reach within healthcare advertising.
Importance 100.0 Sentiment 70.0
per
Lisa Kopp Johnson, Chief Revenue Officer at DeepIntent, expressed excitement about bringing OptimizeRx's EHR network to their client base, emphasizing improved patient outcomes.
Importance 20.0 Sentiment 0.0
per
Steve Silvestro, CEO of OptimizeRx, commented on the integration, highlighting its value for clients and the expansion of programmatic access to the EHR network.
Importance 20.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.